Farmers & Merchants Investments Inc. Has $13.87 Million Stock Holdings in MetLife, Inc. (NYSE:MET)

Farmers & Merchants Investments Inc. lifted its stake in shares of MetLife, Inc. (NYSE:METFree Report) by 2.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,173 shares of the financial services provider’s stock after acquiring an additional 4,794 shares during the period. Farmers & Merchants Investments Inc.’s holdings in MetLife were worth $13,871,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Oak Thistle LLC bought a new stake in shares of MetLife during the 1st quarter valued at approximately $515,000. Claro Advisors LLC bought a new stake in shares of MetLife in the 1st quarter worth $984,000. Kowal Investment Group LLC grew its position in MetLife by 33.5% during the first quarter. Kowal Investment Group LLC now owns 12,696 shares of the financial services provider’s stock valued at $941,000 after buying an additional 3,187 shares during the period. Diversified Trust Co lifted its holdings in MetLife by 110.5% during the first quarter. Diversified Trust Co now owns 12,811 shares of the financial services provider’s stock valued at $949,000 after purchasing an additional 6,724 shares during the last quarter. Finally, LVW Advisors LLC lifted its holdings in MetLife by 64.5% during the first quarter. LVW Advisors LLC now owns 7,224 shares of the financial services provider’s stock valued at $535,000 after purchasing an additional 2,832 shares during the last quarter. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Up 0.4 %

Shares of MetLife stock traded up $0.26 during midday trading on Tuesday, hitting $70.14. The company’s stock had a trading volume of 969,631 shares, compared to its average volume of 3,375,384. The firm has a market capitalization of $49.88 billion, a P/E ratio of 24.02, a PEG ratio of 0.59 and a beta of 1.11. The stock has a 50-day simple moving average of $71.31 and a 200-day simple moving average of $70.16. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.58. MetLife, Inc. has a 1-year low of $56.13 and a 1-year high of $74.68.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, May 1st. The financial services provider reported $1.83 earnings per share for the quarter, meeting the consensus estimate of $1.83. The company had revenue of $17.02 billion for the quarter, compared to analyst estimates of $17.73 billion. MetLife had a return on equity of 20.39% and a net margin of 3.50%. The business’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the company earned $1.52 earnings per share. As a group, sell-side analysts expect that MetLife, Inc. will post 8.62 earnings per share for the current year.

MetLife declared that its Board of Directors has authorized a share buyback program on Wednesday, May 1st that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to purchase up to 6% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 11th. Stockholders of record on Tuesday, May 7th were paid a $0.545 dividend. The ex-dividend date was Monday, May 6th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.11%. This is a boost from MetLife’s previous quarterly dividend of $0.52. MetLife’s payout ratio is 74.91%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on MET. Argus increased their price target on shares of MetLife from $77.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 22nd. Jefferies Financial Group reduced their price target on shares of MetLife from $88.00 to $83.00 and set a “buy” rating for the company in a research report on Friday. JPMorgan Chase & Co. increased their price objective on shares of MetLife from $81.00 to $86.00 and gave the company an “overweight” rating in a report on Tuesday. Wells Fargo & Company lowered their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research report on Friday, May 10th. Finally, Piper Sandler lowered their price target on MetLife from $85.00 to $82.00 and set an “overweight” rating for the company in a research report on Monday, May 6th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.23.

Read Our Latest Research Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.